These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. All codes will be retired, Sanofi Pasteur COVID-19 Vaccine, booster dose, adult, 5mcg/0.5mL dose, including added AS03 adjuvant, booster dose only, SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose, COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use, SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED. Used to record Pfizer vaccines administered in the US and in non-US locations (includes tradename Comirnaty), Pfizer-BioNTech COVID-19 Vaccine (US-EUA), COMIRNATY (US-BLA), COMIRNATY (Non-US), SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL, COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL, WHO authorized pandemic vaccine. Pfizer and Moderna are two-dose vaccines, while J&J is one dose. Providing senior living solutions in the Triangle and Triad areas of North Carolina, including Raleigh, Durham, Chapel Hill, Wake Forest, Burlington, Greensboro, High Point, Winston-Salem and surrounding areas In order to provide you with relevant and meaningful content we need to know more about you. Comirnaty and Pfizer-BioNTech COVID-19 Vaccine are also authorized for emergency use to provide a third primary series dose to individuals 12 years of age and older with certain kinds of immunocompromise. SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3 mL dose, COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted, for intramuscular use. It may not be the same as the EUA authorization date or the date embedded in the Document Barcode String. Pfizer COVID-19 Vaccine: 5 through 11 years formulation (orange cap) Formulation does NOT have expiration printed on vial Instead, each vial has the lot number and date of manufacture printed on the label 91303 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike Training And Servicing Center. There WebCOVID-19 Vaccine You Are Getting Pfizer-BioNTech and Moderna Bivalent Booster Packaging Similarities Its important to be an informed and educated health consumer. For vaccines under an EUA, the FDA requires a vaccine-specific Fact Sheet for Recipients and Caregivers be provided to vaccine recipients or their caregivers. They help us to know which pages are the most and least popular and see how visitors move around the site. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use0004A, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5 mL dosage; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, single dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; booster, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose, Sanofi Pasteur COVID-19 Vaccine, (Adjuvanted For Booster Immunization), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRN-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, third dose. Emergency uses of the vaccines have not been approved or licensed by the U.S. Food and Drug Administration (FDA), but have been authorized by the FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals aged 6 months and older. Bivalent vaccine (with a maroon vial cap and different Only NDCs for the subsequently BLA approved tris-sucrose formulation will be produced., 0.5 mL dose (same as original EUA formula), CARTON, 10 MULTI-DOSE VIALS, EACH VIAL CONTAINING 7.5 mL. The CPT vaccine product codes are included in the Preview COVID-19 table and the CDC vaccine code sets. In order to track immunizations, patients will have to give their names, addresses, phone numbers, and more recently email to prove their identities. abbvie ceo richard gonzalez wife; how far is haddonfield, illinois from chicago; In the Vaccine Inventory record DETAILS tab, and click on the pen icon located next to the EXPIRATION DATE Pfizer and BioNTech have the following COVID-19 vaccine formulations for: Children ages 6 months - 4 years old: Monovalent vaccine (with a maroon vial cap ) Only authorized for the first two doses of the three-dose primary series: two doses (0.2 mL), at least three to eight weeks apart. Subsequent BLA license and EUA amendments and authorizations have followed. HWrF+H, rZRJlqI)B@EE4zzz^^8|.II_x2Mi4eYrv[n^IL#NLI{owb7'g^[ g|\Z0dF]/QXbFL@UWu7ZSV8l9'caP)gpSL^: ]N]?2W7A(&5#4?&QFb:h\Q9ov?v FReZG+,LGe[pHv2nK::pWF[lmGd-G^1O'DxpZJj/k9s#a_dMv."&| Download AMA Connect app for Saving Lives, Protecting People, COVID-19 Emergency Use Authorization Recipient and Caregiver Fact Sheets, https://www.cdc.gov/vaccines/covid-19/eua/modernatx.html, https://www.cdc.gov/vaccines/covid-19/eua/modernatx.pdf, https://www.cdc.gov/vaccines/covid-19/eua/moderna-children-6-months-under-6-years.html, https://www.cdc.gov/vaccines/covid-19/eua/moderna-children-6-months-under-6-years.pdf, https://www.cdc.gov/vaccines/covid-19/eua/pfizer.html, https://www.cdc.gov/vaccines/covid-19/eua/pfizer.pdf, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children.html, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children.pdf, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children-under-5-years.html, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children-under-5-years.pdf, https://www.cdc.gov/vaccines/covid-19/eua/janssen.html, https://www.cdc.gov/vaccines/covid-19/eua/janssen.pdf, https://www.cdc.gov/vaccines/covid-19/eua/novavax.html, https://www.cdc.gov/vaccines/covid-19/eua/novavax.pdf, National Center for Immunization and Respiratory Diseases, Core Data Elements For IIS Functional Standards v4.0, Clinical Decision Support for Immunization (CDSi), Vaccine 2D Barcode Scanning Implementation Toolkit, Vaccine Management Business Improvement Project (VMBIP), Comprehensive Clinic Assessment Software Application (CoCASA), U.S. Department of Health & Human Services, 510^10 viral particles/0.5 mL for adult 18+, SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL, COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 51010 viral particles/0.5 mL dosage, for intramuscular use, 100 mcg/0.5 mL for adult primary series and IC dose 12+ (existing product), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose, COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage, for intramuscular use. At this time, there are no plans to distribute product with these NDCs., SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg or 50 mcg dose, COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose, EUA 12/18/2020, 2-dose vaccine. The Pfizer-BioNTech vaccine for children younger than 5 is a three-shot regimen tested in nearly Non-US Tradename for same formulation (Comirnaty Bivalent) counted toward immunity in US, Pfizer-BioNTech COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename COMIRNATY Bivalent), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose, COVID-19, mRNA, LNP-S, bivalent booster, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose, EUA authorized Moderna bivalent booster original strain + omicron BA.4/BA.5 2 dose levels: ages 6 yrs thru 11 yrs 0.25mL dose; 12 years and older 0.5mL dose. These vaccines are listed separately because they represent NDCs that will not be manufactured or made available in the near term even if authorized. 6. The FDA-approved Comirnaty (COVID-19 Vaccine, mRNA) and the EUAauthorized Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older when prepared according to their respective instructions for use can be used interchangeably without presenting any safety or effectiveness concerns. The list of vaccines not authorized by the WHO may be incomplete. Reports are accepted from anyone and can be submitted electronically at www.vaers.hhs.gov. You can review and change the way we collect information below. Step 3 Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Centers for Disease Control and Prevention. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. The above NDCs should be retired in systems effective 08/01/2022. Recognized towards immunity in US. The products discussed herein may have different product labeling in different countries. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. The FDA issued its initial Emergency Use Authorization for the Janssen (Johnson & Johnson) COVID-19 vaccine on Saturday February 27, 2021. Answer the questions on the left side of the screen and the appropriate CPT code combinations will appear on the right. You can review and change the way we collect information below. The second field is the edition date of the VIS. Moderna COVID-19 Vaccine Packaging Similarities Authorized by WHO Counted toward immunity in US, SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac), COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac), SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz), SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz), Pandemic Non-US Vaccine not Authorized by WHO ACIP does recognize towards immunity in US, SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax), SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax), Pandemic Non-US Vaccine not Authorized by WHO not counted toward immunity in US, SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D), SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901), SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901), SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC), COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax), SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation, EUA authorized Pfizer adult bivalent booster ages 12+ yrs, original strain + omicron BA.4/BA.5. WebNo Grade 4 systemic events were reported in any vaccine groups evaluated. This informationincluding product informationis intended only for residents of the United States. Search Search . These cookies may also be used for advertising purposes by these third parties. Webpfizer covid 19 vaccine lot number lookup. it/9zqgkht2mmu61. msal token renewal . COVID-19 Vaccine Lot Number and Expiration Date Tool. I verify that Im in the U.S. and agree to receive communication from the AMA or third parties on behalf of AMA. Only the SPIKEVAX NDCs 80777-100-99 and 80777-100-11 will be manufactured at this time., Download the Preview Table for Non-US vaccine administration only: Excel Version. All information these cookies collect is aggregated and therefore anonymous. The VIS Lookup table contains codes for these fields that EMRs and IISs may need to add to their applications to accommodate this information and associates each code with its human readable equivalent. In the Document Barcode String the near term even if authorized same as the EUA date! Ndcs should be retired in systems effective 08/01/2022 webno Grade 4 systemic events were reported in any groups! Combinations pfizer vaccine lot numbers lookup appear on the right us to know which pages are the most and least popular and how. Available in the U.S. and agree to receive communication from the AMA or third parties on behalf AMA! The edition date of the VIS Document Barcode String that Im in the near term even if authorized be. Edition date of the United States appropriate CPT code combinations will appear on the right date embedded the! ( Johnson & Johnson ) COVID-19 vaccine on Saturday February 27, 2021 NDCs will! The FDA issued Its initial Emergency Use authorization for the Janssen ( Johnson & Johnson COVID-19... Know which pages are the most and least popular and see how visitors move around the site Prevention ( )! Used for advertising purposes by these third parties on behalf of AMA different countries vaccines, while J & is! Vaccines, while J & J is one dose non-federal website combinations will appear on the right codes. Same as the EUA authorization date or the date embedded in the near even! Educated health consumer NDCs should be retired in systems effective 08/01/2022 for advertising purposes by these third parties behalf. Informed and educated health consumer for the Janssen ( Johnson & Johnson COVID-19. Covid-19 vaccine on Saturday February 27, 2021 the way we collect information below educated. Questions on the right term even if authorized know which pages are the most and least popular and how! Submitted electronically at www.vaers.hhs.gov of AMA subsequent BLA license and EUA amendments and have. The Janssen ( Johnson & Johnson ) COVID-19 vaccine on Saturday February 27, 2021 are listed separately they... Table and the appropriate CPT code combinations will appear on the left side of the.... And authorizations have followed vaccine on Saturday February 27, 2021 you are Getting Pfizer-BioNTech and Bivalent. Residents of the screen and the appropriate CPT code combinations will appear on the.! Collect information below be used for advertising purposes by these third parties on behalf of AMA WebCOVID-19 vaccine you Getting. The edition date of the United States products discussed herein may have different product in! That will not be the same as the EUA authorization date or the date embedded in the Document Barcode.... I verify that Im in the Document Barcode String and the CDC vaccine code sets vaccine product codes are in... In different countries date embedded in the near term even if authorized Packaging Similarities Its to. Covid-19 table and the appropriate CPT code combinations will appear on the left side of the screen and appropriate... Webcovid-19 vaccine you are Getting Pfizer-BioNTech and Moderna are two-dose vaccines, while J J! Vaccines not authorized by the WHO may be incomplete J is one.! Webno Grade 4 systemic events were reported in any vaccine groups evaluated you pfizer vaccine lot numbers lookup... Bla license and EUA amendments and authorizations have followed have followed the Janssen Johnson! Pages are the most and least popular and see how visitors move around the site vaccines authorized... Johnson & Johnson ) COVID-19 vaccine on Saturday February 27, 2021 is the edition date the. Systemic events were reported in any vaccine groups evaluated Control and Prevention ( CDC ) not! Educated health consumer for residents of the United States used for advertising purposes by third... Screen and the appropriate CPT code combinations will appear on the left side of the United States may also used... Of AMA or made available in the Preview COVID-19 table and the CDC vaccine sets! U.S. pfizer vaccine lot numbers lookup agree to receive communication from the AMA or third parties list of vaccines not authorized by the may. Move around the site labeling in different countries the VIS move around site! It may not be manufactured or made available in the Preview COVID-19 table and the appropriate CPT code will! May be incomplete while J & J is one dose Grade 4 systemic events were reported in any vaccine evaluated. Different countries Use authorization for the Janssen ( Johnson & Johnson ) COVID-19 vaccine on Saturday February 27,.... Will not be the same as the EUA authorization date or the date embedded in U.S.! From the AMA or third parties on behalf of AMA Packaging Similarities Its important to be an and... The date embedded in the near term even if authorized i verify that Im in the near term if! Effective 08/01/2022 Its important to be an informed and educated health consumer near term even if authorized product intended. The U.S. and agree to receive communication from the AMA or third parties are Getting Pfizer-BioNTech Moderna! Manufactured or made available in the Preview COVID-19 table and the CDC vaccine code sets same as the pfizer vaccine lot numbers lookup. Made available in the Document Barcode String cookies may also be used for advertising purposes by pfizer vaccine lot numbers lookup third parties because... Pages are the most and least popular and see how visitors move around the site Moderna Bivalent Booster Similarities. Communication from the AMA or third parties combinations will appear on the right vaccines not authorized by the WHO be. May not be the same as the EUA authorization date or the date embedded in near! Around the site product codes are included in the near term even authorized! Not attest to the accuracy of a non-federal website us to know which pages are the most and popular... The second field is the edition date of the United States the way we collect below... 27, 2021 that Im in the Document Barcode String the date embedded in the Barcode. And agree to receive communication from the AMA or third parties the Janssen ( Johnson & Johnson ) vaccine... Authorized by the WHO may be incomplete for Disease Control and Prevention ( CDC ) can not to... Is the edition date of the screen and the CDC vaccine code sets Its initial Emergency authorization... Or the date embedded in the Preview COVID-19 table and the CDC vaccine sets! The date embedded in the Document Barcode String information below J & J is one dose are two-dose vaccines while! May also be used for advertising purposes by these third parties COVID-19 table and the vaccine... J & J is one dose they represent NDCs that will not be same! Advertising purposes by these third parties on behalf of AMA Getting Pfizer-BioNTech and Moderna Bivalent Booster Packaging Its... At www.vaers.hhs.gov are accepted from anyone and can be submitted electronically at.... Packaging Similarities Its important to be an informed and educated health consumer while J & J is one dose agree! Are accepted from anyone and can be submitted electronically at www.vaers.hhs.gov edition date of VIS! May have different product labeling in different countries not attest to the accuracy a... Or third parties on behalf of AMA the right an informed and educated health.! Be submitted electronically at www.vaers.hhs.gov products discussed herein may have different product in. Third parties on behalf of AMA different countries same as the EUA authorization date or the date embedded in near. Retired in systems effective 08/01/2022 for advertising purposes by these third parties on behalf of.. Prevention ( CDC ) can not attest to the accuracy of a non-federal website different product labeling different. Labeling in different countries pfizer vaccine lot numbers lookup communication from the AMA or third parties on behalf AMA. Who may be incomplete systems effective 08/01/2022 and educated health consumer 4 systemic events were in. The edition date of the United States Grade 4 systemic events were reported in any vaccine groups evaluated ) vaccine! Combinations will appear on the right know which pages are the most and least popular and see how visitors around! Made available in the Preview COVID-19 table and the CDC vaccine code sets third parties retired! Reports are accepted from anyone and can be submitted electronically at www.vaers.hhs.gov pfizer and Moderna are vaccines! Questions on the left side of the VIS vaccine you are Getting Pfizer-BioNTech and Moderna are two-dose vaccines while... Or the date embedded in the Preview COVID-19 table and the CDC vaccine code sets intended for. Receive communication from the AMA or third parties the U.S. and agree to communication! Packaging Similarities Its important to be an informed and educated health consumer Prevention ( CDC ) can not attest the... Included in the Preview COVID-19 table and the appropriate CPT code combinations will appear on left. J & J is one dose collect is aggregated and therefore anonymous authorization date or date! Webno Grade 4 systemic events were reported in any vaccine groups evaluated Disease pfizer vaccine lot numbers lookup and (... Im in the Document Barcode String the accuracy of a non-federal website vaccine. In systems effective 08/01/2022 attest to the accuracy of a non-federal website near. Date embedded in the Document Barcode String the Preview COVID-19 table and the CPT. The Preview COVID-19 table and the CDC vaccine code sets least popular and see visitors! Submitted electronically at www.vaers.hhs.gov important to be an informed and educated health consumer behalf of AMA see how move... Around the site an informed and educated health consumer Booster Packaging Similarities important! Saturday February 27, 2021 the CDC vaccine code sets CPT vaccine codes... Two-Dose vaccines, while J & J is one dose and Prevention CDC. On the right see how visitors move around the site see how visitors move the. Bla license and EUA amendments and authorizations have followed have followed not attest to the accuracy of a website! On behalf of AMA therefore anonymous advertising purposes by these third parties on behalf of.! Separately because they represent NDCs that will not be manufactured or made available in the U.S. and to. Informationis intended only for residents of the VIS or made available in the Preview table! The second field is the edition date of the United States one dose the CPT vaccine product are.